Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential IPV and OPV vaccination schedules in 2-month-old infants
ChiCTR-PIR-16009000Phase 3Completed
- Sponsor
- Guangxi Center for Disease Control and Prevention
- Start
- Feb 2015
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of trivalent inactivated polio vaccine, bivalent oral poliovirus vaccine and trivalent oral poliovirus vaccine in poliomyelitis (7 arms), sponsored by Guangxi Center for Disease Control and Prevention. Primary endpoints: Adverse event/reaction rate and Seroconversion rate and antibody level. Started Feb 2015; status: completed.
02
Drugs
trivalent inactivated polio vaccinebivalent oral poliovirus vaccinetrivalent oral poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on ChiCTR-PIR-16009000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PIR-16009000.